LONG Yongchun, TANG Xing, TIAN Xiaoyan, ZHAO Jing. Influence of intravenous thrombolysis with mouse nerve growth factor for injection and recombinant tissue-type plasminogen activator on neurological function of patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2019, 23(11): 7-10. DOI: 10.7619/jcmp.201911002
Citation: LONG Yongchun, TANG Xing, TIAN Xiaoyan, ZHAO Jing. Influence of intravenous thrombolysis with mouse nerve growth factor for injection and recombinant tissue-type plasminogen activator on neurological function of patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2019, 23(11): 7-10. DOI: 10.7619/jcmp.201911002

Influence of intravenous thrombolysis with mouse nerve growth factor for injection and recombinant tissue-type plasminogen activator on neurological function of patients with acute cerebral infarction

More Information
  • Received Date: February 17, 2019
  • Accepted Date: February 17, 2019
  • Available Online: February 22, 2021
  • Published Date: June 14, 2019
  •   Objective  To investigate the influence of intravenous thrombolysis with mouse nerve growth factor for injection and recombinant tissue-type plasminogen activator (rt-PA) on neurological function and serum nerve growth factor (NGF), myelin basic protein (MBP) in patients with acute cerebral infarction (ACI).
      Methods  A total of 98 ACI patients were selected and randomly divided into study group (n=49) and control group (n=49). Both groups were treated with conventional symptomatic treatment after hospital admission. On this basis, the control group was treated with rt-PA by intravenous thrombolysis, while the study group was treated with intravenous thrombolysis with mouse nerve growth factor for injection and rt-PA. The therapeutic effect, NIHSS score and quality of life (SF-36) of the two groups were compared before and after treatment. The serum levels of NGF, MBP and brain-derived neurotrophic factor (BNDF) of the two groups were compared before and after treatment.
      Results  The total effective rate of the study group was 95.92%, which was significantly higher than 81.63% of the control group (P < 0.05). After treatment, the NIHSS score and serum MBP level of the study group were significantly lower than those of the control group, and the levels of NGF and BNDF were significantly higher than those of the control group (P < 0.05). One month after treatment, the scores of vitality, mental health, social function and overall health in the study group were significantly higher than those in the control group (P < 0.05).
      Conclusion  Application of intravenous thrombolysis with mouse nerve growth factor for injection and rt-PA can significantly improve the therapeutic effect, neurological function and quality of life in patients with ACI.
  • [1]
    Camerlingo M, Tudose V, Tognozzi M, et al. Predictors of re-canalisation in acute cerebral infarction from occlusion of the terminal internal carotid artery or of the middle cerebral artery mainstem treated with thrombolysis[J]. Int J Neurosci, 2014, 124(3): 199-203. doi: 10.3109/00207454.2013.836704
    [2]
    杨友高, 冉晓刚, 陈洪宝, 等. 注射用重组人尿激酶原溶栓治疗老年急性脑梗死的临床疗效及其对神经功能和生活质量的影响[J]. 实用药物与临床, 2017, 20(12): 1392-1395. https://www.cnki.com.cn/Article/CJFDTOTAL-LYLC201712031.htm
    [3]
    赵婷. 丹参川芎嗪注射液辅助治疗急性脑梗死对神经功能、血液流变学及炎性细胞因子的影响[J]. 中国合理用药探索, 2017, 14(6): 5-9. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYS201706001.htm
    [4]
    中华医学会神经病学分会. 中国脑血管病影像应用指南[J]. 中华神经科杂志, 2016, 49(3): 164-181. doi: 10.3760/cma.j.issn.1006-7876.2016.03.002
    [5]
    路雅宁, 乔丽云. NIHSS评分在急性脑梗死临床评估中的价值[J]. 生物医学工程与临床, 2015, 19(3): 331-333. doi: 10.3969/j.issn.1009-7090.2015.03.031
    [6]
    张家仕, 冼绍祥. PRO量表及SF-36量表测定高血压患者生活质量效果评价[J]. 广东医学, 2017, 38(16): 2525-2527. doi: 10.3969/j.issn.1001-9448.2017.16.031
    [7]
    胡晓, 瞿浩, 李世容, 等. 静脉溶栓联合亚低温治疗对急性脑梗死患者疗效及可能作用机制的研究[J]. 中国神经精神疾病杂志, 2016, 42(1): 15-21. doi: 10.3969/j.issn.1002-0152.2016.01.004
    [8]
    解燕春, 曾艳平, 张少峰, 等. 重组组织型纤溶酶原激活物静脉溶栓治疗急性轻型脑梗死的疗效观察[J]. 神经损伤与功能重建, 2015, 10(6): 494-496. doi: 10.3870/sjsscj.2015.06.008
    [9]
    陈冬丽, 汪显琪, 李江, 等. 依达拉奉联合Rt-PA静脉溶栓对急性脑梗死病人氧化应激及自由基的影响[J]. 中西医结合心脑血管病杂志, 2017, 15(14): 1775-1778. doi: 10.3969/j.issn.1672-1349.2017.14.031
    [10]
    王荣. 急性脑梗死应用鼠神经生长因子及中成药制剂的临床研究[J]. 临床医学研究与实践, 2017, 2(9): 29-29. https://www.cnki.com.cn/Article/CJFDTOTAL-YLYS201709014.htm
    [11]
    许育伟, 曾宪杰, 何文贞. 重组组织型纤溶酶原激活剂联合鼠神经生长因子对缺血性脑卒中患者疗效的影响[J]. 中国医药科学, 2018, 8(2): 237-239. doi: 10.3969/j.issn.2095-0616.2018.02.073
    [12]
    刘伟, 喻莉. 尤瑞克林联合鼠神经生长因子治疗急性缺血性脑卒中[J]. 实用医学杂志, 2016, 32(21): 3599-3602. doi: 10.3969/j.issn.1006-5725.2016.21.039
    [13]
    凌雪辉. 依达拉奉联合神经节苷脂对急性脑梗死患者血清BDNF、NGF和神经功能缺损的影响[J]. 中国医药导刊, 2016, 18(1): 55-58. https://www.cnki.com.cn/Article/CJFDTOTAL-DKYY201601033.htm
    [14]
    夏翠萍. 急性脑梗死患者监测NGB、BDNF和MBP的临床意义[J]. 临床误诊误治, 2016, 29(12): 81-84. https://www.cnki.com.cn/Article/CJFDTOTAL-LCWZ201612033.htm
    [15]
    但霞. 急性脑梗死患者侧支循环的脑血管造影评估及其与神经功能损伤程度的相关性[J]. 海南医学院学报, 2017, 23(24): 3449-3451. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYY201724032.htm
  • Related Articles

    [1]YU Yanlong, ZHANG Xinqi, LI Hu, LI Ning, YUAN Bo, CHEN Chao, ZHANG Zhuan. Effects of different deflation modes for endotracheal tube cuff on coughing response and hemodynamics during extubation[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 15-19, 24. DOI: 10.7619/jcmp.20232558
    [2]MA Rongrong, TIAN Shunping, SUN Jianhong, ZHANG Zhuan. Research progress of application of oxytocin in gynecological and obstetric surgery and its effect on hemodynamics[J]. Journal of Clinical Medicine in Practice, 2022, 26(3): 134-138. DOI: 10.7619/jcmp.20220294
    [3]ZHOU Yuan, CHEN Haiyan. Effect of different anesthesia methods on hemodynamics and immune function for patients with lung cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(24): 13-16. DOI: 10.7619/jcmp.202024004
    [4]ZHANG Zhian, LEI Guodong. Effect of combined spinal-epidural anesthesia versus general anesthesia on hemodynamics and stress response in patients with hip replacement[J]. Journal of Clinical Medicine in Practice, 2020, 24(13): 80-83. DOI: 10.7619/jcmp.202013023
    [5]ZHENG Ling, ZHU Chongjun. Effects of dexmedetomidine on hemodynamics, agitation in awaken period, and pain degree in pediatric anesthesia[J]. Journal of Clinical Medicine in Practice, 2020, 24(11): 62-64. DOI: 10.7619/jcmp.202011017
    [6]YAO Minglong, CHEN Xiaofei. Influence of different doses of dexmedetomidine on hemodynamics of pregnancy-induced hypertension syndrome patients with cesarean section[J]. Journal of Clinical Medicine in Practice, 2017, (5): 90-92,96. DOI: 10.7619/jcmp.201705025
    [7]LI Yinli. Influence of different dosage of dexmedetomidine combined with general anesthesia on hemodynamics and revival quality of patients[J]. Journal of Clinical Medicine in Practice, 2016, (21): 62-65. DOI: 10.7619/jcmp.201621019
    [8]WU Qian. Influence of general anesthesia combined with epidural anesthesiaon hemodynamics and levels of inflammatory factors in patients with open chest surgery[J]. Journal of Clinical Medicine in Practice, 2016, (7): 72-74,89. DOI: 10.7619/jcmp.201607021
    [9]HU Xuehong, DI Xueyuan, LIU Weidong. Influence of small dose and isobaric bupivacaine on hemodynamics and stress of patients with cesarean section by spinal-epidural anesthesia[J]. Journal of Clinical Medicine in Practice, 2015, (11): 54-56,60. DOI: 10.7619/jcmp.201511016
    [10]TAO Xueyou, LI Xiaoming, NING Ni, ZHAI Haixia, ZUO Meijuan. The effect of Dexmedetomidine on induction period of hemodynamics in patients undergoing general anesthesia combined with epidural block[J]. Journal of Clinical Medicine in Practice, 2014, (5): 125-126,132. DOI: 10.7619/jcmp.201405043
  • Cited by

    Periodical cited type(10)

    1. 张伟. NT-proBNP、D-D、CRP检测在中老年急性脑梗死患者中的临床诊断价值分析. 中国实用医药. 2024(10): 81-84 .
    2. 杨光,毛婷婷,陈红蕾,张海燕. 间质性肺疾病急性加重期患者外周血D-二聚体、B型钠尿肽的检测应用. 锦州医科大学学报. 2024(03): 61-65 .
    3. 刘爱平. 动态检测D-二聚体浓度在急性脑梗死患者溶栓治疗中的意义. 中国实用医药. 2023(05): 89-91 .
    4. 孙培丽,孙贵祥,许秀兰. 急性脑梗死静脉溶栓短期预后的影响因素分析. 北京医学. 2022(03): 209-212 .
    5. 张洁菁,余小萍,沈捷玉. cTnⅠ、Mb、D-D、Hcy水平变化与急性脑梗死患者预后的相关性研究. 黑龙江医药. 2021(02): 447-449 .
    6. 李海燕,肖瑾,刘兵荣,吴婷. 凝血酶原时间、活化部分凝血酶原时间、纤维蛋白原、C反应蛋白、脑钠肽检测对急性脑梗死诊断价值研究. 临床军医杂志. 2020(02): 219-221 .
    7. 刘芳卉. 急性大面积脑梗死患者的临床急救护理措施探讨. 心理月刊. 2020(07): 123 .
    8. 林梓波. 血清指标因子在急性脑梗死治疗前后的评估意义. 黑龙江医药. 2020(04): 933-934 .
    9. 俞峰,郑毅敏,张帅,吴峰. 血清可溶性肿瘤坏死因子样弱凋亡诱导因子、B型利钠肽、基质金属蛋白酶1水平与扩张型心肌病患者左心室重构的关系. 中国基层医药. 2020(12): 1472-1476 .
    10. 王珏,孙杰,徐乾治. 急性脑梗死患者的血浆D-二聚体和N末端B型钠尿肽前体水平及其意义分析. 内科. 2020(05): 592-593+610 .

    Other cited types(1)

Catalog

    Article views (370) PDF downloads (12) Cited by(11)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return